News About <![CDATA[MGT Capital Investments]]> News About en-us <![CDATA[MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference]]> <![CDATA[MGT Capital (MGT) Posts Q1 EPS of $0.24]]> <![CDATA[MGT Capital Investments Announces First Quarter 2013 Results and Outlook]]> <![CDATA[MGT Capital (MGT) to Acquire Online Sports Wagering Site FanTD LLC]]> <![CDATA[MGT Capital Investments, Inc. to Acquire Majority Stake in Fantasy Sports Wagering Business]]> <![CDATA[MGT Capital Investments (MGT) trading halted for news]]> <![CDATA[10 Bizarre Investment Strategies]]> <![CDATA[MGT Capital: Will It Make Millions From Casino Lawsuits?]]> <![CDATA[Unusual 11 Mid-Day Movers 04/09: (FSLR) (GCAP) (JKS) Higher; (BSDM) (MGT) (SHLM) Lower]]> <![CDATA[MGT Capital Investments, Inc. Comments on Recent Trading Activity of Its Common Stock]]> <![CDATA[The Outlook On MGT]]> <![CDATA[MGT Capital Investments, Inc. Engages Munich Innovation Group to Sell MGT’s Legacy Medical Imaging Patents]]> <![CDATA[MGT Capital Investments Regains NYSE MKT Listing Compliance]]> <![CDATA[MGT Capital Investments Announces Shareholders’ Equity of $6.8 Million]]> <![CDATA[MGT Capital Investments (MGT) Files 4.14M Common Secondary Offering]]> <![CDATA[MGT Joins Vringo and VirnetX in Wall Street’s Hottest New Sector: Patents]]> <![CDATA[The Definitive Explanation of the Relationship Between PGLC and CRGC]]> <![CDATA[MGT Shocks Casino Industry, Sues Caesars, MGM, and WMS]]> <![CDATA[MGT Capital Investments Files Patent Infringement Lawsuit Against Caesars Entertainment, MGM Resorts, WMS Gaming, Penn National Gaming and Aruze Gaming]]> <![CDATA[MGT Capital Investments, Inc. Closes $5.9 Million In Equity Financings]]> <![CDATA[Speculation In The Patent Litigation Segment: Finding The Next Big Stock Movers]]> <![CDATA[MGT Capital Investments (MGT) trading halted for order imbalance]]> <![CDATA[MGT Capital (MGT) Paused for Volatility on Resumption, Up 40%+]]> <![CDATA[MGT Capital (MGT) Announces $5.9M Capital Raise]]> <![CDATA[MGT Capital Investments, Inc. Strengthens Balance Sheet with Two Financing Transactions]]> <![CDATA[MGT Capital Investments, Inc. (MGT) halted, news pending]]> <![CDATA[MGT Capital Investments, Inc. Receives Delisting Notice from NYSE MKT Expects to Appeal the Staff’s Determination with Plan to Meet Exchange Standards]]> <![CDATA[MGT Capital (MGT) to Repay $3.5M in Convertible Note Exchange]]> <![CDATA[MGT Capital Investments, Inc. Announces Intent to Pay Off its Notes Ahead of December 2013 Maturity]]> <![CDATA[MGT Capital (MGT) Files $10M Mixed Shelf; 2.86M Common for Selling Shareholders]]> <![CDATA[MGT Capital Investments, Inc. Selects Nixon & Vanderhye P.C. to Pursue Infringement Claims]]> <![CDATA[MGT Capital Investments, Inc. Strengthens Balance Sheet with Institutional Investment]]> <![CDATA[MGT Capital (MGT) Pops on Patent, MGT Gaming Acquisition]]> <![CDATA[MGT Capital Investments, Inc. Announces Gaming Patent Acquisition]]> <![CDATA[MGT Capital (Amex:MGT) Shares Top $5; NYSE Notifies Company About Unusual Activity]]> Tomahawk, WI 3/29/2012 (StreetBeat) – MGT Capital Investments, Inc. (Amex: MGT) said today, in a press release, that there have been no material undisclosed developments which would account for the recent increase in the price of its common stock. Shares of MGT topped out at $5.06 in late trading today on fairly heavy volume and then settled back down to its current price of $3.18 per share, which is still a 66 percent gain.

The NYSE Amex notified the Company today about unusual trading activity in its stock, and the NYSE Amex requested the Company to respond by press release to the unusual activity. The Company's general policy is not to comment on market rumors or speculation including unusual market activity and instead urges investors to look to the Company’s filings with the SEC and its official press releases.

MGT is a holding company comprised of MGT, the parent company, and its wholly-owned subsidiary MGT Capital Investments (U.K.) Limited. In addition we also have a controlling interest in our subsidiary, Medicsight Ltd, including its wholly owned subsidiaries.

Medicsight is a medical technology company with operations in medical imaging software development and medical hardware devices. The company provides a computer-aided detection software application that is used to assist radiologists with early detection and measurement of colorectal polyps. The company’s software received a CE Mark in 2009, as well as clearance from the U. S. FDA in May 2011. Medicsight has also developed an automated carbon dioxide medical inflation device and associated disposable tubing (MedicCO 2 LON) that is being commercialized in partnership with a global distributor.

StreetBeat Disclaimer

Distributed by Viestly

]]> <![CDATA[MGT Capital (Amex:MGT) Shares Top $5; NYSE Notifies Company About Unusual Activity]]> Tomahawk, WI 3/29/2012 (StreetBeat) – MGT Capital Investments, Inc. (Amex: MGT) said today, in a press release, that there have been no material undisclosed developments which would account for the recent increase in the price of its common stock. Shares of MGT topped out at $5.06 in late trading today on fairly heavy volume and then settled back down to its current price of $3.18 per share, which is still a 66 percent gain.

The NYSE Amex notified the Company today about unusual trading activity in its stock, and the NYSE Amex requested the Company to respond by press release to the unusual activity. The Company's general policy is not to comment on market rumors or speculation including unusual market activity and instead urges investors to look to the Company’s filings with the SEC and its official press releases.

MGT is a holding company comprised of MGT, the parent company, and its wholly-owned subsidiary MGT Capital Investments (U.K.) Limited. In addition we also have a controlling interest in our subsidiary, Medicsight Ltd, including its wholly owned subsidiaries.

Medicsight is a medical technology company with operations in medical imaging software development and medical hardware devices. The company provides a computer-aided detection software application that is used to assist radiologists with early detection and measurement of colorectal polyps. The company’s software received a CE Mark in 2009, as well as clearance from the U. S. FDA in May 2011. Medicsight has also developed an automated carbon dioxide medical inflation device and associated disposable tubing (MedicCO 2 LON) that is being commercialized in partnership with a global distributor.

StreetBeat Disclaimer

Distributed by Viestly

]]> <![CDATA[MGT Capital (Amex:MGT) Shares Top $5; NYSE Notifies Company About Unusual Activity]]> Tomahawk, WI 3/29/2012 (StreetBeat) – MGT Capital Investments, Inc. (Amex: MGT) said today, in a press release, that there have been no material undisclosed developments which would account for the recent increase in the price of its common stock. Shares of MGT topped out at $5.06 in late trading today on fairly heavy volume and then settled back down to its current price of $3.18 per share, which is still a 66 percent gain.

The NYSE Amex notified the Company today about unusual trading activity in its stock, and the NYSE Amex requested the Company to respond by press release to the unusual activity. The Company's general policy is not to comment on market rumors or speculation including unusual market activity and instead urges investors to look to the Company’s filings with the SEC and its official press releases.

MGT is a holding company comprised of MGT, the parent company, and its wholly-owned subsidiary MGT Capital Investments (U.K.) Limited. In addition we also have a controlling interest in our subsidiary, Medicsight Ltd, including its wholly owned subsidiaries.

Medicsight is a medical technology company with operations in medical imaging software development and medical hardware devices. The company provides a computer-aided detection software application that is used to assist radiologists with early detection and measurement of colorectal polyps. The company’s software received a CE Mark in 2009, as well as clearance from the U. S. FDA in May 2011. Medicsight has also developed an automated carbon dioxide medical inflation device and associated disposable tubing (MedicCO 2 LON) that is being commercialized in partnership with a global distributor.

StreetBeat Disclaimer

Distributed by Viestly

]]> <![CDATA[MGT Capital (Amex:MGT) Shares Top $5; NYSE Notifies Company About Unusual Activity]]> Tomahawk, WI 3/29/2012 (StreetBeat) – MGT Capital Investments, Inc. (Amex: MGT) said today, in a press release, that there have been no material undisclosed developments which would account for the recent increase in the price of its common stock. Shares of MGT topped out at $5.06 in late trading today on fairly heavy volume and then settled back down to its current price of $3.18 per share, which is still a 66 percent gain.

The NYSE Amex notified the Company today about unusual trading activity in its stock, and the NYSE Amex requested the Company to respond by press release to the unusual activity. The Company's general policy is not to comment on market rumors or speculation including unusual market activity and instead urges investors to look to the Company’s filings with the SEC and its official press releases.

MGT is a holding company comprised of MGT, the parent company, and its wholly-owned subsidiary MGT Capital Investments (U.K.) Limited. In addition we also have a controlling interest in our subsidiary, Medicsight Ltd, including its wholly owned subsidiaries.

Medicsight is a medical technology company with operations in medical imaging software development and medical hardware devices. The company provides a computer-aided detection software application that is used to assist radiologists with early detection and measurement of colorectal polyps. The company’s software received a CE Mark in 2009, as well as clearance from the U. S. FDA in May 2011. Medicsight has also developed an automated carbon dioxide medical inflation device and associated disposable tubing (MedicCO 2 LON) that is being commercialized in partnership with a global distributor.

StreetBeat Disclaimer

Distributed by Viestly

]]> <![CDATA[MGT Capital Investments, Inc. Comments on Recent Price Movement in Its Common Stock]]> <![CDATA[MGT Capital (MGT) Shares Resume, Surge Another ~60%, Halted Again]]> <![CDATA[Shares of MGT Capital (MGT) have been halted on a circuit breaker, now up 96%]]>